VRÁBEL, Dávid, Luděk POUR and Sabina ŠEVČÍKOVÁ. The impact of NF-kappa B signaling on pathogenesis and current treatment strategies in multiple myeloma. BLOOD REVIEWS. EDINBURGH: CHURCHILL LIVINGSTONE, 2019, vol. 34, MAR 2019, p. 56-66. ISSN 0268-960X. Available from: https://dx.doi.org/10.1016/j.blre.2018.11.003.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The impact of NF-kappa B signaling on pathogenesis and current treatment strategies in multiple myeloma
Authors VRÁBEL, Dávid (703 Slovakia, belonging to the institution), Luděk POUR (203 Czech Republic) and Sabina ŠEVČÍKOVÁ (203 Czech Republic, guarantor, belonging to the institution).
Edition BLOOD REVIEWS, EDINBURGH, CHURCHILL LIVINGSTONE, 2019, 0268-960X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30205 Hematology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.823
RIV identification code RIV/00216224:14110/19:00108461
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.blre.2018.11.003
UT WoS 000459839600006
Keywords in English Multiple myeloma; Bone marrow; NF-kappa B; Therapy; Proteasome inhibitor
Tags 14110518, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 16/4/2019 12:18.
Abstract
Multiple myeloma, which ranks as the second most common hematological malignancy, is known for its great genetic heterogeneity. One pathway, however, stands out in this diverse group. NF-kappa B pathway is one of the most important pathways in multiple myeloma not only for its role in pathogenesis, but also for its importance in various treatment strategies. Mutations in several major components of the NF-kappa B pathway and its regulators are present in at least 17% of primary multiple myeloma tumors and 42% of multiple myeloma cell lines. The NF-kappa B pathway regulates numerous genes, which influence development and pathogenesis of multiple myeloma. This significance of NF-kappa B for myeloma cells, however, is used against them, as current treatment strategies often use NF-kappa B as their primary or secondary target.
Links
NV15-29508A, research and development projectName: Cirkulující nukleové kyseliny jako markery progrese mnohočetného myelomu
PrintDisplayed: 13/7/2024 16:36